# US 2024/0197923 A1 · Imidazopyrazine derivatives, process for preparation thereof, and their uses as luciferins

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0197923 A1
- Document ID: US20240197923A1
- Status: Published application
- Kind: A1
- Application number: 18/424,207
- Filed: 2024-01-26
- Published: 2024-06-20
- Earliest claimed: 2017-04-28
- Assignees: Institut Pasteur; Centre National De La Recherche Scientifique
- Applicants: Institut Pasteur; Centre National De La Recherche Scientifique
- Inventors: Yves-Louis JANIN; Eloi Paul COUTANT; Vincent HERVIN; Glwadys GAGNOT; Yves JACOB; Sophie GOYARD; Thierry ROSE
- Web page: https://patentgrep.com/patent/US20240197923A1

## CPC

- A61K 49/0013: {Luminescence}
- C07D 241/16: Halogen atoms; Nitro radicals
- C07D 241/20: Nitrogen atoms (nitro radicals C07D241/16)
- C07D 487/04: Ortho-condensed systems
- G01N 21/763: {Bioluminescence}
- G01N 33/573: for enzymes or isoenzymes
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention is in the field of bioluminescence in biology and/or medicine. In particular, the invention provides imidazopyrazine derivatives, processes for preparation thereof, and their uses as luciferins.

## Claims

### Claim at position 1

1-15. (canceled)

### Claim 16

A method to detect, and/or measure the enzymatic activity of, a luminogenic protein, in vitro, in cellulo, ex vivo or in vivo, comprising a step of contacting a compound of following formula (I) with a solution comprising a strong acid;
wherein:
R1 represents H or a group selected from C1-C6 alkyl, C3-C7 cycloalkyl, C6-C10 aryl, aralkyl and C5-C10-membered heteroaryl groups, said C1-C6 alkyl, C3-C7 cycloalkyl, C6-C10 aryl, aralkyl and C5-C10-membered heteroaryl groups being optionally substituted by at least one Y1 group;
R2 represents a group selected from C6-C10 aryl and C5-C10-membered heteroaryl groups, said C6-C10 aryl and C5-C10-membered heteroaryl groups being optionally substituted by at least one Y2 group;
or R1 and R2 together form with the two carbon atom to which they are respectively attached a C5-C7 cycloalkene group, a C4-C7 heterocycloalkene group, or a C6-C10 arene, said C5-C7 cycloalkene group and C4-C7 heterocycloalkene groups being fused with a C6-C10 arene, said C5-C7 cycloalkene group, C4-C7 heterocycloalkene group, C6-C10 arene, C5-C7 cycloalkene group and C4-C7 heterocycloalkene groups being optionally substituted by at least one Y12 group;
R3 represents H, a C1-C6 alkyl, an aralkyl group, a hetaralkyl group or a heterocycloalkyl-CH2— group, said C1-C6 alkyl, aralkyl group, hetaralkyl group and heterocycloalkyl-CH2— group being optionally substituted by at least one Y3 group;
R4 represents H or a group selected from C1-C6 alkyl and C3-C7 cycloalkyl groups, said C1-C6 alkyl and C3-C7 cycloalkyl groups being optionally substituted by at least one Y4 group;
R5 represents a —C(═O)Ra group or a —C(═O)ORa group, said C(═O)Ra group and —C(═O)ORa group being optionally substituted by at least one Y5 group;
Ra represents H, a C1-C6 alkyl group, a C3-C7 cycloalkyl group, a C6-C10 aryl, or an aralkyl group, said C1-C6 alkyl group, C3-C7 cycloalkyl group, C6-C10 aryl, and aralkyl group being optionally substituted by at least one Ya group;
Z represents a C6-C10 aryl, a C5-C10-membered heteroaryl groups, a C1-C6 alkyl, a C3-C7 cycloalkyl, a C4-C7 heterocycloalkyl, said C6-C10 aryl, C5-C10-membered heteroaryl groups, C1-C6 alkyl, C3-C7 cycloalkyl and C4-C7 heterocycloalkyl being optionally substituted by at least one YZ group;
said Y1, Y2, Y12, Y3, Y4, Y5, Ya and YZ groups being each independently selected from:
a C1-C6 alkyl;
a C3-C7 cycloalkyl;
a C6-C10 aryl;
a C5-C10-membered heteroaryl group;
an halogen;
a —CF3 group;
a —CN group;
a —ORi group;
a —OSO3H group;
a —NRiRii group;
a guanidinyl group;
a —C(═O)ORa group, Ra being as defined above;
Ri and Rii each independently represent H, a C1-C6 alkyl group, a C3-C10 cycloalkyl group, an aralkyl group or an ad hoc protective group; or together form with the nitrogen atom to which they are attached a C4-C7 heterocycloalkyl group.

### Claim 17 (depends on 16)

The method according to claim 16, wherein:
R1 represents H;
R4 represents H;
R5 represents (C═O)Me;
R3 represents an aralkyl group or a hetaralkyl group, optionally substituted;
R2 represents a phenyl, optionally substituted,
and/or
Z is selected from phenyl, furanyl, thiophenyl, and is optionally substituted.

### Claim 18 (depends on 16)

The method according to claim 16, wherein the luminogenic protein is a luciferase derived from Oplophorus luciferase.

### Claim 19

A compound of following formula (III):
wherein:
R1 represents H or a group selected from C1-C6 alkyl, C3-C7 cycloalkyl, C6-C10 aryl, aralkyl and C5-C10-membered heteroaryl groups, said C1-C6 alkyl, C3-C7 cycloalkyl, C6-C10 aryl, aralkyl and C5-C10-membered heteroaryl groups being optionally substituted by at least one Y1 group;
R2 represents a group selected from C6-C10 aryl and C5-C10-membered heteroaryl groups, said C6-C10 aryl and C5-C10-membered heteroaryl groups being optionally substituted by at least one Y2 group;
R3 represents an aralkyl group, said aralkyl group being optionally substituted by at least one Y3 group;
R4 represents H or a group selected from C1-C6 alkyl and C3-C7 cycloalkyl groups, said C1-C6 alkyl and C3-C7 cycloalkyl groups being optionally substituted by at least one Y4 group;
Z represents a group of following formula:
or an oxazolyl, or an oxadiazolyl;
R, R′, R″ and R′″ each independently represent H or a group selected from:
a C1-C6 alkyl group;
a C3-C7 cycloalkyl group;
an halogen;
a —ORi group;
a —CF3 group;
X represents O or S;
said Y1, Y2, Y3 and Y4, groups being each independently selected from:
a C1-C6 alkyl group;
a C3-C7 cycloalkyl group;
an halogen;
a —ORii group;
Ri and Rii each independently represent H, a C1-C6 alkyl group, a C3-C10 cycloalkyl group or an aralkyl group;
provided that:
when Z=Z1:
at least one of R, R′ and R″ does not represent H; or
when R, R′ and R″ represent H, then R2 represents a group selected from C6-C10 aryl and C5-C10-membered heteroaryl groups substituted by at least an halogen group; or R3 represents a group selected from C6-C10 aralkyl groups substituted by at least an halogen group;
when Z=Z2:
at least one of R, R′, R″ and R′″ does not represent H; or
when R, R′, R″ and R′″ represent H; then R2 represents a group selected from C6-C10 aryl and C5-C10-membered heteroaryl groups substituted by at least a halogen group; or R3 represents a group selected from C6-C10 aralkyl groups substituted by at least an halogen group; or
when R, R′ and R′″ represent H and R″ represents a C1-C6 alkyl group or a —ORi group; then R2 does not represent a 4-HO-Ph- group; or R3 represents a group selected from C6-C10 aralkyl groups substituted by at least an halogen group.

### Claim 20 (depends on 19)

The compound according to claim 19, of following formula (IIIa):
wherein:
Z is selected from the group consisting of:

### Claim 21 (depends on 19)

The compound according to claim 19, wherein:
R1 represents H;
R4 represents H;
R3 represents a benzyl group, optionally substituted;
R2 represents a phenyl, optionally substituted,
and/or
Z is selected from Z1 and Z2.

### Claim 22 (depends on 19)

The compound:
according to claim 19, chosen from the compounds having the following names:
8-benzyl-2-((5-methylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-benzyl-2-((5-ethylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-benzyl-2-((4,5-dimethylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-benzyl-6-(2-fluorophenyl)-2-(furan-2-ylmethyl)imidazo[1,2-a]pyrazin-3(7H)-one
8-benzyl-2-(3-methylbenzyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-benzyl-2-(3-methoxybenzyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
2,8-dibenzyl-6-(2-fluorophenyl)imidazo[1,2-a]pyrazin-3(7H)-one
8-benzyl-6-(2,6-difluorophenyl)-2-(furan-2-ylmethyl)imidazo[1,2-a]pyrazin-3(7H)-one
8-benzyl-6-phenyl-2-((5-(trifluoromethyl)furan-2-yl)methyl)imidazo[1,2-a]pyrazin-3(7H)-one
2,8-dibenzyl-6-(2,6-difluorophenyl)imidazo[1,2-a]pyrazin-3(7H)-one
8-benzyl-6-(2-fluorophenyl)-2-((5-methylfuran-2-yl)methyl)imidazo[1,2-a]pyrazin-3(7H)-one
8-benzyl-2-((5-cyclopropylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-benzyl-2-(3-fluorobenzyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-benzyl-2-((5-ethylfuran-2-yl)methyl)-6-(2-fluorophenyl)imidazo[1,2-a]pyrazin-3(7H)-one
8-benzyl-6-(3-fluorophenyl)-2-((5-methylfuran-2-yl)methyl)imidazo[1,2-a]pyrazin-3(7H)-one
8-benzyl-2-(2-fluorobenzyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-benzyl-2-((5-ethylthiophen-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-benzyl-2-((4,5-dimethylfuran-2-yl)methyl)-6-(2-fluorophenyl)imidazo[1,2-a]pyrazin-3(7H)-one
2-benzyl-8-(2-fluorobenzyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
2-benzyl-8-(3-fluorobenzyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-(3-fluorobenzyl)-2-(furan-2-ylmethyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-(2-fluorobenzyl)-2-(3-methylbenzyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-(2-fluorobenzyl)-2-(3-methoxybenzyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-(2-fluorobenzyl)-2-(furan-2-ylmethyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-(2-fluorobenzyl)-2-((5-methylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-(3-fluorobenzyl)-2-(3-methoxybenzyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-(3-fluorobenzyl)-2-(3-methylbenzyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
2-((5-ethylfuran-2-yl)methyl)-8-(3-fluorobenzyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-(2-chlorobenzyl)-2-((5-methylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-(3-fluorobenzyl)-2-((5-methylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
2-((5-ethylfuran-2-yl)methyl)-8-(2-fluorobenzyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-(3-fluorobenzyl)-6-(2-fluorophenyl)-2-((5-methylfuran-2-yl)methyl)imidazo[1,2-a]pyrazin-3(7H)-one
8-(2,3-difluorobenzyl)-2-(furan-2-ylmethyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-(2,3-difluorobenzyl)-2-((5-methylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
2-benzyl-8-(2,3-difluorobenzyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-(2,6-Difluorobenzyl)-2-((5-methylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-(2,3-Difluorobenzyl)-2-((4,5-dimethylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-(2,3-Difluorobenzyl)-2-((5-ethylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-(2,6-Difluorobenzyl)-2-((5-ethylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
2-((4,5-Dimethylfuran-2-yl)methyl)-8-(2-fluorobenzyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
2-((4,5-Dimethylfuran-2-yl)methyl)-8-(3-fluorobenzyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-(2,3-difluorobenzyl)-2-((4-ethyl-5-methylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-(2,3-difluorobenzyl)-2-((5-ethyl-4-methylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
8-benzyl-2-(furan-2-ylmethyl)-6-(3-hydroxyphenyl)imidazo[1,2-a]pyrazin-3(7H)-one;
or chosen from the compounds having the following names:
8-benzyl-2-((5-methylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-benzyl-2-((5-ethylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-benzyl-2-((4,5-dimethylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-benzyl-6-(2-fluorophenyl)-2-(furan-2-ylmethyl)imidazo[1,2-a]pyrazin-3-yl acetate
8-benzyl-2-(3-methylbenzyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-benzyl-2-(3-methoxybenzyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
2,8-dibenzyl-6-(2-fluorophenyl)imidazo[1,2-a]pyrazin-3-yl acetate
8-benzyl-6-(2,6-difluorophenyl)-2-(furan-2-ylmethyl)imidazo[1,2-a]pyrazin-3-yl acetate
8-benzyl-6-phenyl-2-((5-(trifluoromethyl)furan-2-yl)methyl)imidazo[1,2-a]pyrazin-3-yl acetate
2,8-dibenzyl-6-(2,6-difluorophenyl)imidazo[1,2-a]pyrazin-3-yl acetate
8-benzyl-6-(2-fluorophenyl)-2-((5-methylfuran-2-yl)methyl)imidazo[1,2-a]pyrazin-3-yl acetate
8-benzyl-2-((5-cyclopropylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-benzyl-2-(3-fluorobenzyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-benzyl-2-((5-ethylfuran-2-yl)methyl)-6-(2-fluorophenyl)imidazo[1,2-a]pyrazin-3-yl acetate
8-benzyl-6-(3-fluorophenyl)-2-((5-methylfuran-2-yl)methyl)imidazo[1,2-a]pyrazin-3-yl acetate
8-benzyl-2-(2-fluorobenzyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-benzyl-2-((5-ethylthiophen-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-benzyl-2-((4,5-dimethylfuran-2-yl)methyl)-6-(2-fluorophenyl)imidazo[1,2-a]pyrazin-3-yl acetate
2-benzyl-8-(2-fluorobenzyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
2-benzyl-8-(3-fluorobenzyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(3-fluorobenzyl)-2-(furan-2-ylmethyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(2-fluorobenzyl)-2-(3-methylbenzyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(2-fluorobenzyl)-2-(3-methoxybenzyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(2-fluorobenzyl)-2-(furan-2-ylmethyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(2-fluorobenzyl)-2-((5-methylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(3-fluorobenzyl)-2-(3-methoxybenzyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(3-fluorobenzyl)-2-(3-methylbenzyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
2-((5-ethylfuran-2-yl)methyl)-8-(3-fluorobenzyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(2-chlorobenzyl)-2-((5-methylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(3-fluorobenzyl)-2-((5-methylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
2-((5-ethylfuran-2-yl)methyl)-8-(2-fluorobenzyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(2,6-difluorobenzyl)-2-(furan-2-ylmethyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(3,5-difluorobenzyl)-2-(furan-2-ylmethyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(3-chlorobenzyl)-2-(furan-2-ylmethyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(3-fluorobenzyl)-6-(2-fluorophenyl)-2-((5-methylfuran-2-yl)methyl)imidazo[1,2-a]pyrazin-3-yl acetate
8-(2,3-difluorobenzyl)-2-(furan-2-ylmethyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(2,3-difluorobenzyl)-2-((5-methylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(2,5-difluorobenzyl)-2-(furan-2-ylmethyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(2,5-difluorobenzyl)-2-((5-methylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(3,5-difluorobenzyl)-2-((5-methylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
2-benzyl-8-(2,3-difluorobenzyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
2-benzyl-6-phenyl-8-(2-(trifluoromethyl)benzyl)imidazo[1,2-a]pyrazin-3-yl acetate
2-benzyl-6-phenyl-8-(3-(trifluoromethyl)benzyl)imidazo[1,2-a]pyrazin-3-yl acetate
2-benzyl-6-phenyl-8-(2,3,5-trifluorobenzyl)imidazo[1,2-a]pyrazin-3-yl acetate
8-(2,6-Difluorobenzyl)-2-((5-methylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(2,5-Difluorobenzyl)-2-((4,5-dimethylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(2,5-Difluorobenzyl)-2-((5-ethylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(2,3-Difluorobenzyl)-2-((4,5-dimethylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(3,5-Difluorobenzyl)-2-((4,5-dimethylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
2-(furan-2-ylmethyl)-6-phenyl-8-(2,3,5-trifluorobenzyl)imidazo[1,2-a]pyrazin-3-yl acetate
8-(2,3-Difluorobenzyl)-2-((5-ethylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(3,5-Difluorobenzyl)-2-((5-ethylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(2,6-Difluorobenzyl)-2-((5-ethylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(2,6-Difluorobenzyl)-2-((4,5-dimethylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
2-((4,5-Dimethylfuran-2-yl)methyl)-8-(2-fluorobenzyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
2-((4,5-Dimethylfuran-2-yl)methyl)-8-(3-fluorobenzyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-Benzyl-6-phenyl-2-((5-propylfuran-2-yl)methyl)imidazo[1,2-a]pyrazin-3-yl acetate (133)
8-(2,3-difluorobenzyl)-2-((4-ethyl-5-methylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-benzyl-2-((4-ethyl-5-methylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-benzyl-2-((5-isopropyl-4-methylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-benzyl-2-((5-ethyl-4-methylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(2,3-difluorobenzyl)-2-((5-ethyl-4-methylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-benzyl-2-(1-(furan-2-yl)ethyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-(2,3-difluorobenzyl)-2-((5-isopropyl-4-methylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl acetate
8-benzyl-2-(furan-2-ylmethyl)-6-(3-hydroxyphenyl)imidazo[1,2-a]pyrazin-3-yl acetate;
or
chosen from the compounds of the following names:
2-((3-benzyl-5-phenylpyrazin-2-yl)amino)-3-(5-methyl(23)furan-2-yl)propanoic acid
2-((3-benzyl-5-phenylpyrazin-2-yl)amino)-3-(5-ethylfuran-2-yl)propanoic acid
2-((3-benzyl-5-phenylpyrazin-2-yl)amino)-3-(4,5-dimethylfuran-2-yl)propanoic acid
2-((3-benzyl-5-(2-fluorophenyl)pyrazin-2-yl)amino)-3-(furan-2-yl)propanoic acid
2-((3-benzyl-5-phenylpyrazin-2-yl)amino)-3-(m-tolyl)propanoic acid
2-((3-benzyl-5-phenylpyrazin-2-yl)amino)-3-(3-methoxyphenyl)propanoic acid
(3-benzyl-5-(2-fluorophenyl)pyrazin-2-yl)phenylalanine
2-((3-benzyl-5-(2,6-difluorophenyl)pyrazin-2-yl)amino)-3-(furan-2-yl)propanoic acid
2-((3-benzyl-5-phenylpyrazin-2-yl)amino)-3-(5-(trifluoromethyl)furan-2-yl)propanoic acid
(3-benzyl-5-(2,6-difluorophenyl)pyrazin-2-yl)phenylalanine
2-((3-benzyl-5-(2-fluorophenyl)pyrazin-2-yl)amino)-3-(5-methylfuran-2-yl)propanoic acid
2-((3-benzyl-5-phenylpyrazin-2-yl)amino)-3-(5-cyclopropylfuran-2-yl)propanoic acid
2-((3-benzyl-5-phenylpyrazin-2-yl)amino)-3-(3-fluorophenyl)propanoic acid
2-((3-benzyl-5-(2-fluorophenyl)pyrazin-2-yl)amino)-3-(5-ethylfuran-2-yl)propanoic acid
2-((3-benzyl-5-(3-fluorophenyl)pyrazin-2-yl)amino)-3-(5-methylfuran-2-yl)propanoic acid
2-((3-benzyl-5-phenylpyrazin-2-yl)amino)-3-(2-fluorophenyl)propanoic acid
2-((3-benzyl-5-phenylpyrazin-2-yl)amino)-3-(5-ethylthiophen-2-yl)propanoic acid
2-((3-benzyl-5-(2-fluorophenyl)pyrazin-2-yl)amino)-3-(4,5-dimethylfuran-2-yl)propanoic acid
(3-(2-fluorobenzyl)-5-phenylpyrazin-2-yl)phenylalanine
(3-(3-fluorobenzyl)-5-phenylpyrazin-2-yl)phenylalanine
2-((3-(3-fluorobenzyl)-5-phenylpyrazin-2-yl)amino)-3-(furan-2-yl)propanoic acid
2-((3-(2-fluorobenzyl)-5-phenylpyrazin-2-yl)amino)-3-(m-tolyl)propanoic acid
2-((3-(2-fluorobenzyl)-5-phenylpyrazin-2-yl)amino)-3-(3-methoxyphenyl)propanoic acid
2-((3-(2-fluorobenzyl)-5-phenylpyrazin-2-yl)amino)-3-(furan-2-yl)propanoic acid
2-((3-(2-fluorobenzyl)-5-phenylpyrazin-2-yl)amino)-3-(5-methylfuran-2-yl)propanoic acid
2-((3-(3-fluorobenzyl)-5-phenylpyrazin-2-yl)amino)-3-(3-methoxyphenyl)propanoic acid
2-((3-(3-fluorobenzyl)-5-phenylpyrazin-2-yl)amino)-3-(m-tolyl)propanoic acid
3-(5-ethylfuran-2-yl)-2-((3-(3-fluorobenzyl)-5-phenylpyrazin-2-yl)amino)propanoic acid
2-((3-(2-chlorobenzyl)-5-phenylpyrazin-2-yl)amino)-3-(5-methylfuran-2-yl)propanoic acid
2-((3-(3-fluorobenzyl)-5-phenylpyrazin-2-yl)amino)-3-(5-methylfuran-2-yl)propanoic acid
3-(5-ethylfuran-2-yl)-2-((3-(2-fluorobenzyl)-5-phenylpyrazin-2-yl)amino)propanoic acid,
3-(3-(2,6-difluorobenzyl)-5-phenylpyrazin-2-yl)-2-(furan-2-ylmethyl)propanoic acid
3-(3-(3,5-difluorobenzyl)-5-phenylpyrazin-2-yl)-2-(furan-2-ylmethyl)propanoic acid
3-(3-(3-chlorobenzyl)-5-phenylpyrazin-2-yl)-2-(furan-2-ylmethyl)propanoic acid
3-(3-(3-fluorobenzyl)-5-(2-fluorophenyl)pyrazin-2-yl)-2-((5-methylfuran-2-yl)methyl)propanoic acid
3-(3-(2,3-difluorobenzyl)-5-phenylpyrazin-2-yl)-2-(furan-2-ylmethyl)propanoic acid
3-(3-(2,3-difluorobenzyl)-5-phenylpyrazin-2-yl)-2-((5-methylfuran-2-yl)methyl)propanoic acid
3-(3-(2,5-difluorobenzyl)-5-phenylpyrazin-2-yl)-2-(furan-2-ylmethyl)propanoic acid
3-(3-(2,5-difluorobenzyl)-5-phenylpyrazin-2-yl)-2-((5-methylfuran-2-yl)methyl)propanoic acid
3-(3-(3,5-difluorobenzyl)-5-phenylpyrazin-2-yl)-2-((5-methylfuran-2-yl)methyl)propanoic acid
2-benzyl-3-(3-(2,3-difluorobenzyl)-5-phenylpyrazin-2-yl)propanoic acid
2-benzyl-3-(5-phenyl-3-(2-(trifluoromethyl)benzyl)pyrazin-2-yl)propanoic acid
2-benzyl-3-(5-phenyl-3-(3-(trifluoromethyl)benzyl)pyrazin-2-yl)propanoic acid
2-benzyl-3-(5-phenyl-3-(2,3,5-trifluorobenzyl)pyrazin-2-yl)propanoic acid
3-(3-(2,6-difluorobenzyl)-5-phenylpyrazin-2-yl)-2-((5-methylfuran-2-yl)methyl)propanoic acid
3-(3-(2,5-difluorobenzyl)-5-phenylpyrazin-2-yl)-2-((4,5-dimethylfuran-2-yl)methyl)propanoic acid
3-(3-(2,5-difluorobenzyl)-5-phenylpyrazin-2-yl)-2-((5-ethylfuran-2-yl)methyl)propanoic acid
3-(3-(2,3-difluorobenzyl)-5-phenylpyrazin-2-yl)-2-((4,5-dimethylfuran-2-yl)methyl)propanoic acid
3-(3-(3,5-difluorobenzyl)-5-phenylpyrazin-2-yl)-2-((4,5-dimethylfuran-2-yl)methyl)propanoic acid
3-(furan-2-yl)-2-((5-phenyl-3-(2,3,5-trifluorobenzyl)pyrazin-2-yl)methyl)propanoic acid
3-(3-(2,3-difluorobenzyl)-5-phenylpyrazin-2-yl)-2-((5-ethylfuran-2-yl)methyl)propanoic acid
3-(3-(3,5-difluorobenzyl)-5-phenylpyrazin-2-yl)-2-((5-ethylfuran-2-yl)methyl)propanoic acid
3-(3-(2,6-difluorobenzyl)-5-phenylpyrazin-2-yl)-2-((5-ethylfuran-2-yl)methyl)propanoic acid
3-(3-(2,6-difluorobenzyl)-5-phenylpyrazin-2-yl)-2-((4,5-dimethylfuran-2-yl)methyl)propanoic acid
3-(4,5-dimethylfuran-2-yl)-2-((3-(2-fluorobenzyl)-5-phenylpyrazin-2-yl)methyl)propanoic acid
3-(4,5-dimethylfuran-2-yl)-2-((3-(3-fluorobenzyl)-5-phenylpyrazin-2-yl)methyl)propanoic acid
2-((3-(2,3-difluorobenzyl)-5-phenylpyrazin-2-yl)amino)-3-(4-ethyl-5-methylfuran-2-yl)propanoic acid
2-((3-benzyl-5-phenylpyrazin-2-yl)amino)-3-(4-ethyl-5-methylfuran-2-yl)propanoic acid
2-((3-benzyl-5-phenylpyrazin-2-yl)amino)-3-(5-isopropyl-4-methylfuran-2-yl)propanoic acid
2-((3-benzyl-5-phenylpyrazin-2-yl)amino)-3-(5-ethyl-4-methylfuran-2-yl)propanoic acid
2-((3-(2,3-difluorobenzyl)-5-phenylpyrazin-2-yl)amino)-3-(5-ethyl-4-methylfuran-2-yl)propanoic acid
2-((3-benzyl-5-phenylpyrazin-2-yl)amino)-3-(furan-2-yl)butanoic acid
2-((3-(2,3-difluorobenzyl)-5-phenylpyrazin-2-yl)amino)-3-(5-isopropyl-4-methylfuran-2-yl)propanoic acid
2-((3-benzyl-5-(3-(benzyloxy)phenyl)pyrazin-2-yl)amino)-3-(furan-2-yl)propanoic acid
2-((3-benzyl-5-(3-(hydroxy)phenyl)pyrazin-2-yl)amino)-3-(furan-2-yl)propanoic acid.

### Claim 23 (depends on 19)

A compound of following formula (VII):
wherein:
Y represents a leaving group;
R1 represents H or a group selected from C1-C6 alkyl, C3-C7 cycloalkyl, C6-C10 aryl, aralkyl and C5-C10-membered heteroaryl groups, said C1-C6 alkyl, C3-C7 cycloalkyl, C6-C10 aryl, aralkyl and C5-C10-membered heteroaryl groups being optionally substituted by at least one Y1 group;
R2 represents a group selected from C6-C10 aryl and C5-C10-membered heteroaryl groups, said C6-C10 aryl and C5-C10-membered heteroaryl groups being optionally substituted by at least one Y2 group;
R3 represents an aralkyl group, said aralkyl group being optionally substituted by at least one Y3 group;
said Y1, Y2 and Y3 groups being each independently selected from:
a C1-C6 alkyl group;
a C3-C7 cycloalkyl group;
an halogen;
a —ORii group;
Rii represents H, a C1-C6 alkyl group, a C3-C10 cycloalkyl group or an aralkyl group;
with the proviso that said compound is not of one of the following formulae:
or the combination of compound as recited in claim 19.

### Claim 24 (depends on 19)

A method of diagnostic comprising contacting a compound of formula (III) as defined in claim 19 with an in vitro or ex vivo sample.

### Claim 25 (depends on 19)

A method of diagnostic comprising a step of administering an effective amount of a compound of formula (III) as defined in claim 19 to a subject in need thereof.

### Claim 26

A method of preparation of a compound of a compound of following formula (III):
wherein:
R1 represents H or a group selected from C1-C6 alkyl, C3-C7 cycloalkyl, C6-C10 aryl, aralkyl and C5-C10-membered heteroaryl groups, said C1-C6 alkyl, C3-C7 cycloalkyl, C6-C10 aryl, aralkyl and C5-C10-membered heteroaryl groups being optionally substituted by at least one Y1 group;
R2 represents a group selected from C6-C10 aryl and C5-C10-membered heteroaryl groups, said C6-C10 aryl and C5-C10-membered heteroaryl groups being optionally substituted by at least one Y2 group;
R3 represents an aralkyl group, said aralkyl group being optionally substituted by at least one Y3 group;
R4 represents H or a group selected from C1-C6 alkyl and C3-C7 cycloalkyl groups, said C1-C6 alkyl and C3-C7 cycloalkyl groups being optionally substituted by at least one Y4 group;
Z represents a group of following formula:
or an oxazolyl, or an oxadiazolyl;
R, R′, R″ and R′″ each independently represent H or a group selected from:
a C1-C6 alkyl group;
a C3-C7 cycloalkyl group;
an halogen;
a —ORi group;
a —CF3 group;
X represents O or S;
said Y1, Y2, Y3 and Y4, groups being each independently selected from:
a C1-C6 alkyl group;
a C3-C7 cycloalkyl group;
an halogen;
a —ORii group;
Ri and Rii each independently represent H, a C1-C6 alkyl group, a C3-C10 cycloalkyl group or an aralkyl group;
provided that:
when Z=Z1:
at least one of R, R′ and R″ does not represent H; or
when R, R′ and R″ represent H, then R2 represents a group selected from C6-C10 aryl and C5-C10-membered heteroaryl groups substituted by at least an halogen group; or R3 represents a group selected from C6-C10 aralkyl groups substituted by at least an halogen group;
when Z=Z2:
at least one of R, R′, R″ and R′″ does not represent H; or
when R, R′, R″ and R′″ represent H; then R2 represents a group selected from C6-C10 aryl and C5-C10-membered heteroaryl groups substituted by at least a halogen group; or R3 represents a group selected from C6-C10 aralkyl groups substituted by at least an halogen group; or
when R, R′ and R′″ represent H and R″ represents a C1-C6 alkyl group or a —ORi group; then R2 does not represent a 4-HO-Ph- group; or R3 represents a group selected from C6-C10 aralkyl groups substituted by at least an halogen group, comprising a step of conversion of a compound of formula (IV) as defined as follows into a compound of formula (III):
wherein:
R1 represents H or a group selected from C1-C6 alkyl, C3-C7 cycloalkyl, C6-C10 aryl, aralkyl and C5-C10-membered heteroaryl groups, said C1-C6 alkyl, C3-C7 cycloalkyl, C6-C10 aryl, aralkyl and C5-C10-membered heteroaryl groups being optionally substituted by at least one Y1 group;
R2 represents a group selected from C6-C10 aryl and C5-C10-membered heteroaryl groups, said C6-C10 aryl and C5-C10-membered heteroaryl groups being optionally substituted by at least one Y2 group;
R3 represents an aralkyl group, said aralkyl group being optionally substituted by at least one Y3 group;
R4 represents H or a group selected from C1-C6 alkyl and C3-C7 cycloalkyl groups, said C1-C6 alkyl and C3-C7 cycloalkyl groups being optionally substituted by at least one Y4 group;
Z represents a group of following formula:
or an oxazolyl, or an oxadiazolyl;
R, R′, R″ and R′″ each independently represent H or a group selected from:
a C1-C6 alkyl group;
a C3-C7 cycloalkyl group;
an halogen;
a —ORi group;
a —CF3 group;
X represents O or S;
said Y1, Y2, Y3 and Y4, groups being each independently selected from:
a C1-C6 alkyl group;
a C3-C7 cycloalkyl group;
an halogen;
a —ORii group;
Ri and Rii each independently represent H, a C1-C6 alkyl group, a C3-C10 cycloalkyl group or an aralkyl group;
provided that:
when Z=Z1:
at least one of R, R′ and R″ does not represent H; or
when R, R′ and R″ represent H, then R2 represents a group selected from C6-C10 aryl and C5-C10-membered heteroaryl groups substituted by at least an halogen group, in particular —F, R2 representing in particular a 2-F-phenyl, a 3-F-phenyl, or a 2,6-diF-phenyl group; or R3 represents a group selected from C6-C10 aralkyl groups substituted by at least an halogen group, in particular —F;
when Z=Z2:
at least one of R, R′, R″ and R′″ does not represent H; or
when R, R′, R″ and R′″ represent H; then R2 represents a group selected from C6-C10 aryl and C5-C10-membered heteroaryl groups substituted by at least a halogen group, in particular —F, R2 representing in particular 2-F-phenyl, a 3-F-phenyl, or a 2,6-diF-phenyl group; or R3 represents a group selected from C6-C10 aralkyl groups substituted by at least an halogen group, in particular —F; or
when R, R′ and R′″ represent H and R″ represents a C1-C6 alkyl group or a —ORi group; then R2 does not represent a 4-HO-Ph- group, R2 representing in particular a phenyl group or a group selected from C6-C10 aryl and C5-C10-membered heteroaryl groups substituted by at least a halogen group, in particular —F, R2 representing more particularly a 2-F-phenyl, a 3-F-phenyl, or a 2,6-diF-phenyl group; or R3 represents a group selected from C6-C10 aralkyl groups substituted by at least an halogen group, in particular —F,
R5 represents a —C(═O)Ra group or a —C(═O)ORa group, said C(═O)Ra group and —C(═O)ORa group being optionally substituted by at least one Y5 group, wherein Ra represents H, a C1-C6 alkyl group, a C3-C7 cycloalkyl group, a C6-C10 aryl, or an aralkyl group, said C1-C6 alkyl group, C3-C7 cycloalkyl group, C6-C10 aryl, and aralkyl group being optionally substituted by at least one Ya group.

### Claim 27 (depends on 26)

The method according to claim 26, comprising a step of conversion of the compound of formula (IV) into a compound of formula (III), by contacting said compound of formula (IV) with a strong acid.

### Claim 28 (depends on 26)

The method according to claim 26, wherein said compound of formula (IV) is prepared according to a process comprising:
i) A step of conversion of a compound of following formula (VI):
wherein:
R1, R2, R3, R4 and Z are as defined for formula (IV);
Rd represents a group selected from C1-C6 alkyl, C3-C7 cycloalkyl and aralkyl, into a compound of following formula (V):
wherein R1, R2, R3, R4 and Z are as defined for formula (IV),
followed by a step of conversion of the compound of formula (V) into a compound of formula (IV); or
ii) A step of conversion of a compound of formula (VI) as defined above into a compound of formula (IV).

### Claim 29 (depends on 28)

The method according to claim 28, wherein said compound of formula (VI) is obtained from a process comprising:
i) a step of replacement of the hydroxyl group of a compound of following formula (VIII):
by a leaving group —Y, Y being in particular an halogen, to give a compound of following formula (VII):
and
ii) A step of contacting the compound of following formula (VII):
with a compound of following formula (IX):
thereby obtaining a compound of formula (VI).
